Moreinx AB - Company Review
Moreinx AB - Company ReviewSummary
MoreinX AB (MoreinX) is a research and development company that specializes in the development and commercialization of vaccine adjuvant and drug delivery. The company develops CANQURA, a nano-based G3 Technology used in the treatment of cancers through cell normalization. Its duecom concept specializes in oncology that provides positive indications for cancer such as prostate, ovarian, leukaemia, liver, pancreatic, and kidney cancer. MoreinX created a new adjuvant called ADJUVAQ a third-generation adjuvant that is used in animal and human vaccines and also used as carriers of vaccine antigen produced by genetic engineering product. The company’s drug delivery platform involves in making the insoluble substances to soluble for pharmaceuticals and nutraceuticals areas. MoreinX is headquartered in Uppsala, Sweden.
This comprehensive company report of Moreinx AB provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.